Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
48,823,503
-
Shares change
-
-42,902
-
Total reported value, excl. options
-
$526,594,567
-
Value change
-
-$9,059,452
-
Put/Call ratio
-
3%
-
Number of buys
-
73
-
Number of sells
-
-64
-
Price
-
$10.78
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2014
192 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2014.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48,823,503 shares
of 294,683,714 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include FMR LLC (6,122,775 shares), WASATCH ADVISORS INC (2,970,812 shares), ADAGE CAPITAL PARTNERS GP LLC (2,550,000 shares), State Street Corp (2,533,186 shares), BlackRock Fund Advisors (2,300,729 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2,152,179 shares), VANGUARD GROUP INC (2,043,798 shares), BlackRock Institutional Trust Company, N.A. (1,961,386 shares), JENNISON ASSOCIATES LLC (1,768,392 shares), and JANUS CAPITAL MANAGEMENT LLC (1,306,092 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.